microRNA Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Consumables); By Services (Service Type, Specimen); By Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease); By End-Use; By Regions; Segment Forecast, 2021 - 2028

报告摘要

The global microRNA market was valued at USD 856.9 million in 2020 and is expected to grow at a CAGR of 20.1% during the forecast period. The key market factors shaping the future include emerging microRNA tools for varied disease-associated applications, the use of microRNA in prediction and identification, and as the potential candidate for biopharma companies to develop future medicines. Biopharma firms across the globe, are engaged in developing new molecules as a potential drug candidate also driving the microRNA market growth.

了解有关此报告的更多信息：request for sample pages

Several microRNA-based candidates are undergoing clinical trials such as anti-microRNA compounds and potential inhibitors, which could be employed in different potential therapeutic applications. Thus, RNA therapeutics is being considered as a booming investing area, which will have led to the development of profitable drugs.

市场上新开发的方法包括基于RCA的方法，无酶扩增，基于灯的方法，基于DSN的方法和基于纳米粒子的扩增。在这一行中，在2020年1月，从事有关部门的研究人员开发了一种等温放大技术，以测量MicroRNA的定量测量。据估计，在该系统中，污染减少，因为它取决于信号放大过程，与其他方法相比，这可以进一步提高其效率。

microRNA Market Report Scope

The market is primarily segmented on the basis of products, services, application, and region.

由产品	通过服必威开户注册务	通过申请	按地区
Instrument 消耗品	Service Type 隔离和纯化 miRNA cDNA合成 分析，本地化和量化 功能分析 Others 标本 全血 血清 Plasma FFPE. 新鲜的冷冻组织 Others	癌症 传染性疾病 免疫障碍 Cardiovascular Disease 神经疾病 Others	北美（美国，加拿大） 欧洲（法国，德国，英国，意大利，西班牙，荷兰，奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西，墨西哥，阿根廷） 中东和非洲（沙特阿拉伯，阿联酋，以色列，南非）

了解有关此报告的更多信息：request for sample pages

产品洞察力

The wired consumables market segment accounted for the largest revenue share, in 2020. Such a high share is attributed to the availability of a wide range of consumables in microRNA profiling such as detection kits, primers, reagents, among others.

通过耗材时采用消耗品，在程序期间是必不可少的商品，并定期更换。该行业中的一些重要市场参与者包括Thermo Fisher，Nanostring和Miltenyi Biotec。

On the basis of the instrument, the real-time PCR dominated the concerned market segment and is considered as a gold standard, when compared to other techniques to detect microRNA. It is routinely used as a reliable technique to detect microRNA expression, due to its dynamic range, high specificity, and enhanced sensitivity. It is currently being used as a broad range of research applications such as validation, functional analysis, profiling, and quantification.

在市场研究期间预计NGS旨在目睹利润丰厚的市场增长。它是一种强大的工具，以实现基因的系统性研究，并为更好地理解这种疾病提供研究见解。

NGS还与许多信息型解决方案集成，可以允许更快地处理复杂的MicroRNA序列数据。在这一行中，CAP-Mirseq允许深度微罗纳测序，加工，变体识别和微罗纳密码子中的对准。此外，它允许更快的处理，并允许更容易的下游分析和质量评估。

应用洞察力

2020年,癌症的细分市场占the largest share. Such a high share is primarily due to the increase in the prevalence of cancer cases, the significant importance of cancer cases in disease pathology, and concerning innovations in microRNA role in cancer diagnosis via cancer-associated genomic regions.

There are several tumor suppressor microRNAs that are usually suppressed during translation of microRNAs, which encodes for the oncogenes, inhibiting tumor formation and cancer development. Thus, microRNA dysregulation is well understood to find therapeutic action to treat different forms of cancer in the market.

MicroRNAs具有未受保护的末端，使其易于通过核糖核酸酶降解，使它们能够在有限的时间内表达自己。为了克服这些挑战，研究人员对微大车衫开发了有效的交付系统。

在这条线中，最近开发的纳米颗粒输送系统被认为是递送MicroRNA的有吸引力的选择。已经使用了几种制剂，例如天然存在的二氧化硅树枝状大分子，有机基脂质纳米粒子和聚酰胺胺。

地理概述

2020年，北美市场占全球MicroRNA市场的45％以上。为该地区的市场增长有所促进的因素包括在基因组，肿瘤和蛋白质组学方面建立了重点市场参与者的关键市场参与者，并在基因组学和蛋白质组学方面建立了研究基础设施，以及硅片功能。

Moreover, companies in the region are extensively involved in research on microRNA-based biomarkers. In this direction, in May 2020, DiamiR received approval for its patent for the microRNA-based method, to be used for monitoring brain aging. It covers methods for quantitative analysis of miRNA in blood plasma and brain blood vessels.

竞争洞察力

The prominent market players operating in the microRNA market are Merck KgaA, Thermo Fisher, BioGenex, New England Biolabs, Horizon Discovery, GeneCopoeia, Quantabio, NanoString, SeqMatic LLC, Sistemic Scotland Limited, Synlogic, QIAGEN, Miltenyi Biotec, Biodynamics Laboratory Inc., OriGene Technologies.